Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway
Tóm tắt
Từ khóa
Tài liệu tham khảo
Philippon, 2002, Plasmid‐determined AmpC‐type beta‐lactamases, Antimicrob Agents Chemother, 46, 1, 10.1128/AAC.46.1.1-11.2002
Lee, 2007, Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid‐mediated CMY‐2 and DHA‐1 beta‐lactamases co‐mediated by porin loss, Int J Antimicrob Agents, 29, 201, 10.1016/j.ijantimicag.2006.09.006
Gazouli, 1997, Study of an outbreak of cefoxitin‐resistant Klebsiella pneumoniae in a general hospital, J Clin Microbiol, 35, 508, 10.1128/JCM.35.2.508-510.1997
M’Zali, 1997, Transcontinental importation into the UK of Escherichia coli expressing a plasmid‐mediated AmpC‐type beta‐lactamase exposed during an outbreak of SHV‐5 extended‐spectrum beta‐lactamase in a Leeds hospital, J Antimicrob Chemother, 40, 823, 10.1093/jac/40.6.823
Bauernfeind, 1996, Comparative characterization of the cephamycinase blaCMY‐1 gene and its relationship with other beta‐lactamase genes, Antimicrob Agents Chemother, 40, 1926, 10.1128/AAC.40.8.1926
Kang, 2006, Variability in the region downstream of the blaCMY‐2 beta‐lactamase gene in Escherichia coli and Salmonella enterica plasmids, Antimicrob Agents Chemother, 50, 1590, 10.1128/AAC.50.4.1590-1593.2006
Hopkins, 2006, Replicon typing of plasmids carrying CTX‐M or CMY beta‐lactamases circulating among Salmonella and Escherichia coli isolates, Antimicrob Agents Chemother, 50, 3203, 10.1128/AAC.00149-06
Verdet, 2000, A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla (DHA‐1) gene and its regulator gene ampR, originated from Morganella morganii, Antimicrob Agents Chemother, 44, 222, 10.1128/AAC.44.1.222-225.2000
Haldorsen, 2008, The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1‐like ampC element or hyperproduction of the endogenous AmpC, J Antimicrob Chemother, 62, 694, 10.1093/jac/dkn257
Mammeri, 2008, Molecular characterization of AmpC‐producing Escherichia coli clinical isolates recovered in a French hospital, J Antimicrob Chemother, 61, 498, 10.1093/jac/dkm538
Coudron, 2000, Occurrence and detection of AmpC beta‐lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center, J Clin Microbiol, 38, 1791, 10.1128/JCM.38.5.1791-1796.2000
Perez‐Perez, 2002, Detection of plasmid‐mediated AmpC beta‐lactamase genes in clinical isolates by using multiplex PCR, J Clin Microbiol, 40, 2153, 10.1128/JCM.40.6.2153-2162.2002
Tofteland, 2007, Effects of phenotype and genotype on methods for detection of extended‐spectrum‐beta‐lactamase‐producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway, J Clin Microbiol, 45, 199, 10.1128/JCM.01319-06
Arduino, 2002, blaCTX‐M‐2 is located in an unusual class 1 integron (In35) which includes Orf513, Antimicrob Agents Chemother, 46, 2303, 10.1128/AAC.46.7.2303-2306.2002
Clermont, 2002, Rapid and simple determination of the Escherichia coli phylogenetic group, Appl Environ Microbiol, 66, 4555, 10.1128/AEM.66.10.4555-4558.2000
Naseer, 2007, Nosocomial outbreak of CTX‐M‐15‐producing E. coli in Norway, APMIS, 115, 120, 10.1111/j.1600-0463.2007.apm_547.x
Wirth, 2006, Sex and virulence in Escherichia coli: an evolutionary perspective, Mol Microbiol, 60, 1136, 10.1111/j.1365-2958.2006.05172.x
Hall, 1999, BioEdit: a user‐friendly biological sequence alignment editor and analysis program for Windows 95/98/NT, Nucleic Acids Symp Ser, 41, 95
Carattoli, 2005, Identification of plasmids by PCR‐based replicon typing, J Microbiol Methods, 63, 219, 10.1016/j.mimet.2005.03.018
Barton, 1995, A general method for detecting and sizing large plasmids, Anal Biochem, 226, 235, 10.1006/abio.1995.1220
NORM/NORM‐VET. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø/Oslo 2008 ISSN:1502‐2307. 2007.
Walther‐Rasmussen, 2002, Plasmid‐borne AmpC beta‐lactamases, Can J Microbiol, 48, 479, 10.1139/w02-039
Li, 2008, Prevalence of plasmid‐mediated AmpC beta‐lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY‐2‐Type AmpC beta‐lactamase resistance in China, J Clin Microbiol, 46, 1317, 10.1128/JCM.00073-07
Hopkins, 2006, Characterisation of CTX‐M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales, Int J Antimicrob Agents, 28, 180, 10.1016/j.ijantimicag.2006.03.027
Poirel, 2005, ISEcp1B‐mediated transposition of blaCTX‐M in Escherichia coli, Antimicrob Agents Chemother, 49, 447, 10.1128/AAC.49.1.447-450.2005
Suzuki, 2009, Change in the prevalence of extended‐spectrum‐beta‐lactamase‐producing Escherichia coli in Japan by clonal spread, J Antimicrob Chemother, 63, 72, 10.1093/jac/dkn463
D’Andrea, 2006, CMY‐16, a novel acquired AmpC‐type beta‐lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy, Antimicrob Agents Chemother, 50, 618, 10.1128/AAC.50.2.618-624.2006
Lau, 2008, UK epidemic Escherichia coli strains A‐E, with CTX‐M‐15 {beta}‐lactamase, all belong to the international O25:H4‐ST131 clone, J Antimicrob Chemother, 62, 1241, 10.1093/jac/dkn380
Nicolas‐Chanoine, 2008, Intercontinental emergence of Escherichia coli clone O25:H4‐ST131 producing CTX‐M‐15, J Antimicrob Chemother, 61, 273, 10.1093/jac/dkm464
Lau, 2008, Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing, J Clin Microbiol, 46, 1076, 10.1128/JCM.02065-07
Jones, 2008, Prevalence and distribution of plasmid‐mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended‐spectrum beta‐lactamases, J Antimicrob Chemother, 62, 1245, 10.1093/jac/dkn406
Cagnacci, 2008, European emergence of ciprofloxacin‐resistant Escherichia coli clonal groups O25:H4‐ST 131 and O15:K52:H1 causing community‐acquired uncomplicated cystitis, J Clin Microbiol, 46, 2605, 10.1128/JCM.00640-08
Leflon‐Guibout, 2008, Absence of CTX‐M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France, J Clin Microbiol, 46, 3900, 10.1128/JCM.00734-08